|Bid||130.05 x 1800|
|Ask||132.40 x 900|
|Day's Range||128.43 - 131.54|
|52 Week Range||127.80 - 189.00|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||30.70|
|Earnings Date||Nov 01, 2021 - Nov 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||207.82|
September's been a rough month for the stock market, and on Monday, the S&P 500 had its worst day in months, falling 1.7%. Instead, it may be time to load up on three growth stocks near their 52-week lows, including Jazz Pharmaceuticals (NASDAQ: JAZZ), Activision Blizzard (NASDAQ: ATVI), and Alibaba Group Holding (NYSE: BABA). Healthcare company Jazz Pharmaceuticals is trading at around $130 and has been falling more than 20% year to date, while the S&P 500 has risen by 16%.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, October 13, 2021 at 4:30 p.m. ET / 9:30 p.m. IST to provide an update on Xywav® (calcium, magnesium, potassium and sodium oxybates), the first and only U.S. Food and Drug Administration-approved treatment for idiopathic hypersomnia (IH) in adults, which was approved on August 12, 2021.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in the following upcoming virtual investor conferences: